raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:38874

Dihydropyrimidinuria

Synonyms: Dihydropyrimidinase deficiency

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Childhood, Infancy
Status
active

Dihydropyrimidinase (DPD) deficiency is a very rare pyrimidine metabolism disorder with a variable clinical presentation including gastrointestinal manifestations (feeding problems, cyclic vomiting, gastroesophageal reflux, malabsorption with villous atrophy), hypotonia, intellectual deficit, seizures, and less frequently growth retardation, failure to thrive, microcephaly and autism. Asymptomatic cases are also reported. DPD deficiency increases the risk of 5-FU toxicity.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enDihydropyrimidinuriaDihydropyrimidinase deficiency
frDihydropyrimidinurieDéficit en dihydropyrimidinase
deDihydropyrimidinurieDihydropyrimidinase-Mangel
esDihidropirimidinuriaDeficiencia de dihidropirimidinasa
itDiidropirimidinuriaDeficit di diidropirimidinasi
nlDihydropyrimidinurieDeficiëntie van dihydropyrimidinase
ptDiidropirimidinúriaDeficiência de diidropirimidinase
plDihydropirymidynuriaNiedobór dihydropirymidynazy
csDihydropyrimidinurieDeficit dihydropyrimidinázy
ukДигідропіримідинуріяДефіцит дигідропіримідинази
zh二氢嘧啶尿二氢嘧啶酶缺乏症
trDihidropirimidinüriDihidropirimidinaz eksikliği

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM222748Evalidated
ICD-10E79.8NTBTattributedvalidated
ICD-115C55.1NTBTindexvalidated
MONDO0009111Evalidated
UMLSC3495551Evalidated
GARD12347Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
DPYSDisease-causing germline mutation(s) (loss of function) inAssessedHGNC:3013ENSG000001476476133268q22.3dihydropyrimidinase9718352[PMID]_20362666[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_26771602[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

20 annotations · validated 2025-07-22
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:6000119Elevated urinary dihydrothymine level
HP:6000118Elevated urinary dihydrouracil level
HP:6000331Elevated urinary thymine level
HP:0001249Intellectual disability
HP:0001250Seizure
HP:0012127Uraciluria
Occasional (29-5%)
HP:0007018Attention deficit hyperactivity disorder
HP:0000717Autism
HP:0000280Coarse facial features
HP:0001508Failure to thrive
HP:0011968Feeding difficulties
HP:0002020Gastroesophageal reflux
HP:0001510Growth delay
HP:0001252Hypotonia
HP:0000256Macrocephaly
HP:0000252Microcephaly
HP:0012758Neurodevelopmental delay
HP:0011473Villous atrophy
HP:0002013Vomiting
Very rare (<4-1%)
HP:0002376Developmental regression

Annotation source: 38199782[PMID]_29054612[PMID]_20362666[PMID]

7

Sources for this card